Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive ALL

This randomized trial assesses the effect of ponatinib vs imatinib combined with low-intensity chemotherapy on disease remission in adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (ALL).